Gingival fibroblast response to cyclosporin A and transforming growth factor β1

Journal of Periodontal Research

Volumn 33, Issue 1, 1998, Pages 40-48

  James, J A ^a,c   Irwin, C R ^b   Linden, G J ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c UNIVERSITY DENTAL HOSPITAL OF MANCHESTER   (United Kingdom)

Author keywords

Cyclosporin A; Fibroblasts; Gingival overgrowth; Transforming growth factor 1

Indexed keywords

COLLAGEN; COLORING AGENT; CYCLOSPORIN; DIAGNOSTIC AGENT; IMMUNOSUPPRESSIVE AGENT; PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CLASSIFICATION; COMPARATIVE STUDY; CONNECTIVE TISSUE; CULTURE MEDIUM; DRUG EFFECT; EPITHELIUM; EXTRACELLULAR MATRIX; FIBROBLAST; GEL; GINGIVA; GINGIVA OVERGROWTH; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PATHOLOGY; PROTEIN SYNTHESIS;

ADULT; ANALYSIS OF VARIANCE; CELLS, CULTURED; COLLAGEN; COLORING AGENTS; CONNECTIVE TISSUE; CULTURE MEDIA; CYCLOSPORINE; EPITHELIUM; EXTRACELLULAR MATRIX; FIBROBLASTS; GELS; GINGIVA; GINGIVAL OVERGROWTH; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; MALE; PROTEIN BIOSYNTHESIS; PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031608194     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.1998.tb02290.x     Document Type: Article

References (35)

1. Seymour RA, Jacobs DJ. Cyclosporin A and the gingival tissues. J Clin Periodont 1992; 19: 1-11.
2. Kahan BD. Cyclosporine. N Engl J Med 1989; 321: 1725-1739.
3. Barclay S, Thomason JM, Idle JR, et al. The incidence and severity of gingival overgrowth. J Clin Periodont 1992; 19: 311-314.
4. Seymour RA, Smith DG, Rogers SR. The comparative effects of azathioprine and cyclosporin on some gingival health parameters of renal transplant patients. J Clin Periodont 1987; 14: 610-613.
5. McGaw WT, Lam S, Coates J. Cyclosporin A-induced gingival overgrowth: correlations with dental plaque scores, gingivitis scores and cyclosporin levels in serum and saliva. Oral Surg Oral Med Oral Pathol 1987; 64: 293-297.
6. Hefti AF, Eshenaur AE, Hassell TN, et al. Gingival overgrowth and cyclosporin A treated multiple sclerosis patients. J Periodontol 1994; 65: 744-749.
7. Roberts AB, Anzano MA, Meyers CA, et al. Purification and properties of a type β transforming growth factor from bovine kidney. Biochemistry 1983; 22: 5692-5698.
8. Barnard JA, Lyons RM, Moses HL. The cell biology of transforming growth factor-β. Biochim Biophvs Acta 1990; 1032: 79-87.
9. Wolf G, Thaiss F, Stahl RA. Cyclosporine stimulates expression of transforming growth factor-beta in renal cells. Possible mechanisms of cyclosporines proliferative effects. Transplantation 1995; 60: 237-241.
10. Shehata M, Cope GH, Johnson TS, et al. Cyclosporine enhances the expression of TGF-beta in the juxtaglomerular cells of the rat kidney. Kidney Int 1995; 48: 1487-1496.
11. Noble N, Harper JR, Border WA. In vivo interactions of TGF-β and extracellular matrix. Prog Growth Factor Res 1992; 4: 369-382.
12. Penttonen RP, Kobayashi S, Bornstein P. Transforming growth factor-β increases mRNA for matrix proteins both in the presence and the absence of changes in mRNA stability. Proc Natl Acad Sci USA 1988; 85: 1105-1108.
13. Babu MRD, Oliver N. Keloid fibroblasts exhibit an altered response to TGFβ. J Invest Dermatol 1992; 99: 650-655.
14. Saito K, Mori S. Iwakura M, Sakamoto S. Immunohistochemical localization of transforming growth factor b, basic fibroblast growth factor and heparan sulphate glycosaminoglycan in gingival hyperplasia induced by nifedipine and phenytoin. J Periodont Res 1996; 31: 545-555.
15. Wysocki GP, Gretzinger HA, Laupacis A, et al. Fibrous hyperplasia of the gingiva: a side effect of cyclosporin A therapy. Oral Surg Oral Med Oral Pathol 1983; 55: 274-278.
16. Deliliers GL, Santoro F, Polli N, et al. Light and electron microscopic study of cyclosporin A-induced gingival hyperplasia. J Periodontol 1986; 57: 771-775.
17. 1 on protein production by mouse embryonic palatal mesenchymal cells in the presence or absence of serum. Archs Oral Biol 1992; 37: 39-48.
18. Narayanan AS, Page RC, Swanson J. Collagen synthesis by human fibroblasts: regulation by transforming growth factor-β in the presence of other inflammatory mediators. Biochem J 1989; 260: 463-469.
19. Irwin CR, Schor SI, Ferguson MWJ. Effects of cytokines on gingival fibroblasts in vitro are modulated by the extracellular matrix. J Periodont Res 1994; 29: 309-317.
20. James JA, Irwin CR, Linden GJ. The effects of culture environment on the response of human gingival fibroblasts to cyclosporin A. J Periodontol 1995; 66: 339-344.
21. Bell E, Ivarsson B, Merrill C. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci USA 1979; 76: 1274-1278.
22. Peterofsky B, Diegelmann R. Use of a mixture of proteinase free collagenases for the specific assay of radioactive collagen in the presence of other proteins. Biochemistry 1971; 10: 988-994.
23. Loef EB, Proper JA, Goustin AS, Shipley GD, Di Corleto PE, Moses HL. Induction of c-sis mRNA and platelet derived growth factor-like activity by transforming growth factor, type B, a proposed model for indirect mitogenesis involving autocrine activity. Proc Natl Acad Sci USA 1986; 83: 2454 2457.
24. Igarashi A, Okochi M, Bradman D, Grotendorst G. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 1993; 4: 637-645.
25. 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA 1991; 88: 6642-6646.
26. Shihab FS, Yamamoto T, Nast CC, et al. TGF-β and matrix protein expression in acute and chrome rejection of human renal allografts. J Am Soc Nephrol 1995; 6: 286-294.
27. 1 in rats with experimental silicosis, alveolar type II hyperplasia and lung cancer. Am J Pathol 1993; 142: 1831-1840.
28. Li B, Sehajpal PK, Khanna A, Vlassara H, Cerami A, Stenzel KH, Suthanthiran M. Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction. J Exp Med 1991; 5: 1259-1562.
29. Irwin CR, Picardo M, Ellis I, et al. Inter- and intra-site heterogeneity in the expression of fetal-like phenotypic characteristics by gingival fibroblasts: potential significance for wound healing. J Cell Sci 1994; 107: 1333-1346.
30. Ignotz RA, Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986; 261: 4337-4345.
31. McKevitt KMB, Irwin CR. Phenotypic differences in growth, matrix synthesis and response to nifedipine between fibroblasts derived from clinically healthy and overgrown gingiva. J Oral Pathol Med 1995; 24: 66-71.
32. Tipton DA, Fry HR, Dabbous M. Altered collagen metabolism in nifedipine-induced gingival overgrowth. J Periodont Res 1994; 29: 401-409.
33. Williamson MS, Miller EK, Plemmons J, Rees T, Iacopino AM. Cyclosporine A upregulates interleukin-6 expression in human gingiva: possible mechanism for gingival overgrowth. J Periodontol 1994; 65: 895-903.
34. Plemmons JM, Dill RE, Rees TD, Dyer BJ, Ng MC, Iacopino AM. PDGF-β producing cells and PDGF-β gene expression in normal gingiva and Cyclosporine A-induced gingival overgrowth. J Periodontol 1996; 67: 264-270.
35. Nares S, Ng MC, Dill RE, Park B, Cutler CW, Iacopino AM. Cyclosporine A upregulates platelet-derived growth factor aβ chain in hyperplastic human gingiva. J Periodontol 1996; 67: 271-289.